Maria Jose Cavagnaro

Maria Jose Cavagnaro

Auto-generated profile, based on publicly available information

Maria Jose Cavagnaro

Department of Neurosurgery, Stanford University, Stanford, CA 94304, USA

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 August 2025 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
VSVivek Sanker
Vivek Sanker
PSPoorvikha Satish
Poorvikha Satish
Alexander ThallerAlexander Thaller
Alexander Thaller
ZLZhikai Li
Zhikai Li
Philip HeesenPhilip Heesen
Philip Heesen
ADAtman Desai
Atman Desai
Background: Spinal metastasis is the third most common site for metastatic localization, following the lung and liver. Manual detection through imaging modalities such as CT, MRI, PET, and bone scintigraphy can be costly and inefficient. Preliminary artificial intelligence (AI) techniques and computer-aided detection (CAD) systems have attempted to improve lesion detection, segmentation, and treatment response in oncological imaging. The objective of this review is to evaluate the current applications of AI across multimodal imaging techniques in the diagnosis of spinal metastasis. Methods: Databases like PubMed, Scopus, Web of Science Advance, Cochrane, and Embase (Ovid) were searched using specific keywords like ‘spine metastases’, ‘artificial intelligence’, ‘machine learning’, ‘deep learning’, and ‘diagnosis’. The screening of studies adhered to the PRISMA guidelines. Relevant variables were extracted from each of the included articles such as the primary tumor type, cohort size, and prediction model performance metrics: area under the receiver operating curve (AUC), accuracy, sensitivity, specificity, internal validation and external validation. A random-effects meta-analysis model was used to account for variability between the studies. Quality assessment was performed using the PROBAST tool. Results: This review included 39 studies published between 2007 and 2024, encompassing a total of 6267 patients. The three most common primary tumors were lung cancer (56.4%), breast cancer (51.3%), and prostate cancer (41.0%). Four studies reported AUC values for model training, 16 for internal validation, and five for external validation. The weighted average AUCs were 0.971 (training), 0.947 (internal validation), and 0.819 (external validation). The risk of bias was the highest in the analysis domain, with 22 studies (56%) rated high risk, primarily due to inadequate external validation and overfitting. Conclusions: AI-based approaches show promise for enhancing the detection, segmentation, and characterization of spinal metastatic lesions across multiple imaging modalities. Future research should focus on developing more generalizable models through larger and more diverse training datasets, integrating clinical and imaging data, and conducting prospective validation studies to demonstrate meaningful clinical impact.

15 December 2021 in Frontiers in Pediatrics
Verified
Journal Article
Open access
MZMINGYI ZHAO
MINGYI ZHAO
SXShaokang Xu
Shaokang Xu
MCMaría José Cavagnaro
María José Cavagnaro
WZWei Zhang
Wei Zhang
JSJian Shi
Jian Shi
Background: As an important autoimmune disease, type 1 diabetes (T1D) is often diagnosed in children, but due to the complexity of the etiology of diabetes and many other factors, the disease pathogenesis of diabetes is still unclear. The intestinal microbiota has been proved to have close relationships with T1D in recent years, which is one of the most important molecular bases of pathogenesis and prognosis factors for T1D. Using the multi-omics and multicenter sample analysis method, a number of intestinal microbiota in T1D have been discovered and explained, which has provided comprehensive and rich information. However, how to find more useful information and get an intuitive understanding that people need conveniently in the huge data sea has become the focus of attention. Therefore, quantitative analysis and visualization of the interaction between intestinal microbiota and T1D in children are urgently needed.Methods: We retrieved the detailed original data from the National Center for Biotechnology Information, GMREPO, and gutMEGA databases and other authoritative multiple projects with related research; the ranking of intestinal microbiota abundance from healthy people, overall T1D patients, and T1D in children (0–18 years old) were detailed analyzed, classified, and visualized.Results: A total of 515 bacterial species and 161 related genera were fully analyzed. Also, Prevotella copri was led by 21.25% average abundance, followed by Clostridium tertium of 10.39% in all-cross T1D patients. For children with T1D, Bacteroides vulgatus has high abundance in all age periods, whereas the abundance of each intestinal microbiota was more uniform in female samples, with the ranking from high to low as Bacteroides dorei 9.56%, P. copri 9.53%, Streptococcus pasteurianus 8.15%, and C. tertium 7.53%, whereas in male samples, P. copri was accounted for the largest by 22.72%. The interaction between intestinal microbiota and comparison between healthy people and children with T1D was also detailed analyzed.Conclusions: This study provides a new method and comprehensive perspectives for the evaluation of the interaction between intestinal microbiota and T1D in children. A set of useful information of intestinal microbiota with its internal interaction and connections has been presented, which could be a compact, immediate, and practical scientific reference for further molecular biological and clinical translational research of T1D in children.

20 August 2025 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
VSVivek Sanker
Vivek Sanker
PDPrachi Dawer
Prachi Dawer
Alexander ThallerAlexander Thaller
Alexander Thaller
ZLZhikai Li
Zhikai Li
Philip HeesenPhilip Heesen
Philip Heesen
ADAtman Desai
Atman Desai
Background: Spinal metastases can cause significant impairment of neurological function and quality of life. Hence, personalized clinical decision-making based on prognosis and likely outcome is desirable. The effectiveness of AI in predicting complications and treatment outcomes for patients with spinal metastases is assessed. Methods: A thorough search was carried out through the PubMed, Scopus, Web of Science, Embase, and Cochrane databases up until 27 January 2025. Included were studies that used AI-based models to predict outcomes for adult patients with spinal metastases. Three reviewers independently extracted the data, and screening was conducted in accordance with PRISMA principles. AUC results were pooled using a random-effects model, and the PROBAST program was used to evaluate the study’s quality. Results: Included were 47 articles totaling 25,790 patients. For training, internal validation, and external validation, the weighted average AUCs were 0.762, 0.876, and 0.810, respectively. The Skeletal Oncology Research Group machine learning algorithms (SORG-MLAs) were the ones externally validated the most, continuously producing AUCs > 0.84 for 90-day and 1-year mortality. Models based on radiomics showed promise in preoperative planning, especially for outcomes of radiation and concealed blood loss. Most research concentrated on breast, lung, and prostate malignancies, which limited its applicability to less common tumors. Conclusions: AI models have shown reasonable accuracy in predicting mortality, ambulatory status, blood loss, and surgical complications in patients with spinal metastases. Wider implementation necessitates additional validation, data standardization, and ethical and regulatory framework evaluation. Future work should concentrate on creating multimodal, hybrid models and assessing their practical applications.

30 April 2026 in Neurospine
Verified
Journal Article
Open access
DADaniyal Ashraf
Daniyal Ashraf
VSVivek Sanker
Vivek Sanker
LLLinda Liverani
Linda Liverani
CPChelsea Park
Chelsea Park
RMRavi Teja Medikonda
Ravi Teja Medikonda
ADAtman Desai
Atman Desai
Spine imaging represents a complex diagnostic frontier characterized by anatomical variability, motion artifacts, metallic instrumentation interference, and significant inter-reader diagnostic variability (κ=0.20 across institutions). While conventional discriminative artificial intelligence (AI) models achieve >95% accuracy in detecting degenerative changes, they remain limited by data scarcity, heterogeneous protocols, and poor generalizability. In the spine, these limitations are particularly relevant because clinical decisions can often depend on subtle distinctions (such as differentiating levels of canal or foraminal stenosis, characterizing Modic endplate changes, or assessing pedicle and vertebral morphology), where small inconsistencies can meaningfully alter management or surgical planning. Generative AI (GenAI) systems—including generative adversarial networks (GANs), diffusion models, and vision-language models (VLMs)—offer a paradigm shift by learning underlying data structures to generate high-quality synthetic outputs rather than merely classifying existing data. This narrative review, conducted using SANRA (scale for the assessment of narrative review articles) methodology across PubMed, Scopus, Embase, and Cochrane Library, examined GenAI applications in spine imaging. Eligible studies included observational designs through randomized controlled trials exploring image reconstruction, synthetic computed tomography (CT) generation, segmentation, and surgical planning applications. GAN-generated synthetic magnetic resonance imaging sequences reduce scan times by ~40% while maintaining diagnostic confidence; diffusion models enable radiation-free synthetic CT for preoperative planning; and VLMs generate structured radiology reports with hallucination rates <1.12%. However, critical barriers impede clinical translation: external validation gaps reveal AI performance collapse in real-world cohorts (sensitivity drops to 54.9% in cervical fracture detection); hallucinations and anatomical inaccuracies risk misguiding implant sizing; bias amplification magnifies demographic underrepresentation; and fragmented, small datasets lack standardized benchmarks. Technical fragility, computational demands, clinician trust deficits, and unresolved regulatory frameworks for iteratively-updating systems remain unaddressed. Successful integration requires coordinated development across 5 priorities: (1) multi-institutional datasets with cross-vendor harmonization, (2) federated learning frameworks preserving privacy, (3) uncertainty quantification and explainability tools, (4) outcome-linked clinical validation replacing technical metrics, and (5) workflow-integrated systems with DICOM-native interfaces and provenance tracking.

23 July 2025 in Bioengineering
Verified
Journal Article
Open access
PDF file
VSVivek Sanker
Vivek Sanker
SSSai Sanikommu
Sai Sanikommu
Alexander ThallerAlexander Thaller
Alexander Thaller
ZLZhikai Li
Zhikai Li
PHPhilip Heesen
Philip Heesen
ADAtman Desai
Atman Desai
Background: Spinal metastases (SMs) are associated with poor prognosis and significant morbidity. We hypothesize that artificial intelligence (AI) models can enhance the identification and clinical utility of genetic and molecular signatures associated with SMs, improving diagnostic accuracy and enabling personalized treatment strategies. Methods: A systematic review of five databases was conducted to identify studies that used AI to predict genetic alterations and SMs outcomes. Accuracy, area under the receiver operating curve (AUC), and sensitivity were used for comparison. Data analysis was performed in R. Results: Eleven studies met the inclusion criteria, covering three different primary tumor origins, comprising a total of 2211 patients with an average of 201 ± 90 patients (range: 76–359 patients) per study. EGFR, Ki-67, and HER-2 were studied in ten (90.9%), two (18.1%), and one (9.1%) study, respectively. The weighted average AUC is 0.849 (95% CI: 0.835–0.863) and 0.791 (95% CI: 0.738–0.844) for internal and external validation of the established models, respectively. Conclusions: AI, through radiomics and machine learning, shows strong potential in predicting molecular markers in SMs. Our study demonstrates that AI can predict molecular markers in SMs with high accuracy.

28 June 2024 in Surgical Neurology International
Verified
Journal Article
Open access
RCRenuka Chintapalli
Renuka Chintapalli
DPDhiraj Pangal
Dhiraj Pangal
MCMaria-Jose Cavagnaro
Maria-Jose Cavagnaro
MGMaria Isabel Barros Guinle
Maria Isabel Barros Guinle
TJThomas Johnstone
Thomas Johnstone
JRJohn Ratliff
John Ratliff
Background: The relative safety and more widespread utility of an adhesive surface electrode-based neuromonitoring (ABM) system may reduce the time and cost of traditional needle-based neuromonitoring (NBM). Methods: This retrospective cohort review included one- and two-level transforaminal lumbar interbody fusion procedures (2019–2023). The primary variables studied included were time (in minutes) from patient entry into the operating room (OR) to incision, time from patient entry into the OR to closure, and time from incision to closure. Univariate and bivariate analyses were performed to compare the outcomes between the ABM (31 patients) and NBM (51 patients) modalities. Results: We found no significant differences in the time from patient entry into the OR to incision (ABM: 71.8, NBM: 70.3, P = 0.70), time from patient entry into the OR to closure (ABM: 284.2, NBM: 301.7, P = 0.27), or time from incision to closure (ABM: 212.4, NBM: 231.4, P = 0.17) between the two groups. Further, no patients from either group required reoperation for mal-positioned instrumentation, and none sustained a new postoperative neurological deficit. The ABM approach did, however, allow for a reduction in neurophysiologist-workforce and neuromonitoring costs. Conclusion: The introduction of the ABM system did not lower surgical time but did demonstrate similar efficacy and clinical outcomes, with reduced clinical invasiveness, neurophysiologist-associated workforce, and overall neuromonitoring cost compared to NBM.